Tag: ANDA filing

Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Medications 0
By Frankie Torok 7 December 2025

Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents

Paragraph IV patent challenges let generic drug makers legally fight brand patents to bring cheaper medicines to market faster. Under the Hatch-Waxman Act, these challenges have saved patients over $1.2 trillion since 1990.